PPARG and nephrolithiasis: Thus, our study not only discovered the role of imbalanced mitochondrial dynamics in kidney stone-related renal dysfunction but also further elucidated the intrinsic molecular mechanisms by which PPARγ agonist alleviates the progression of kidney stones.